Skip to main content
Year archive

IMMUTEP LIMITED — 2021 filings

All 109 regulatory filings released by IMMUTEP LIMITED (IMM) in 2021, sourced directly from the official regulator.

109 Filings
2021 Period
2021 filings (109)
Filing Released Lang
Immutep Advances IMP761 Manufacturing 3 pages 264.7KB
Capital/Financing Update
2021-12-15 English
Amended Constitution 47 pages 559.5KB
Governance Information
2021-12-13 English
Change of Registered Office Address 1 page 208.1KB
Regulatory Filings
2021-12-13 English
Change in substantial holding 6 pages 858.0KB
Major Shareholding Notification
2021-12-05 English
Good safety reported from 1st five patients in INSIGHT-003 2 pages 223.5KB
Regulatory Filings
2021-12-01 English
Notification regarding unquoted securities - IMM 5 pages 26.7KB
Share Issue/Capital Change
2021-12-01 English
Application for quotation of securities - IMM 6 pages 28.0KB
Capital/Financing Update
2021-11-30 English
Change of Director's Interest Notice - Mr Voigt 3 pages 222.8KB
Director's Dealing
2021-11-30 English
Change of Director's Interest Notice - Dr. Howard 3 pages 224.0KB
Director's Dealing
2021-11-30 English
Notification regarding unquoted securities - IMM 7 pages 29.7KB
Capital/Financing Update
2021-11-29 English
Proposed issue of securities - IMM 5 pages 27.7KB
Capital/Financing Update
2021-11-29 English
Immutep AGM 2021 - Chairman's Address 3 pages 223.0KB
AGM Information
2021-11-25 English
Immutep AGM 2021 - CEO's Presentation 22 pages 1.1MB
AGM Information
2021-11-25 English
Results of Meeting 2 pages 265.0KB
Declaration of Voting Results & Voting Rights Announcements
2021-11-25 English
Phase II TACTI-002 trial recruitment successfully completed 3 pages 269.0KB
Capital/Financing Update
2021-11-18 English
Immutep Global Webcast Slides to Discuss Clinical Results 32 pages 2.8MB
Investor Presentation
2021-11-16 English
Change in substantial holding 6 pages 2.6MB
Major Shareholding Notification
2021-11-16 English
Change in substantial holding 6 pages 230.3KB
Major Shareholding Notification
2021-11-15 English
Chinese Patent Granted for Efti with PD-1 Pathway Inhibitors 2 pages 215.5KB
Regulatory Filings
2021-11-14 English
Immutep announces publication of SITC 2021 posters 8 pages 558.1KB
Regulatory Filings
2021-11-14 English
Final Phase IIb AIPAC clinical trial results for Efti in MBC 4 pages 324.7KB
Regulatory Filings
2021-11-09 English
Immutep announces publication of SITC 2021 abstracts 2 pages 292.9KB
Report Publication Announcement
2021-11-09 English
JobKeeper Payment Notice 2 pages 252.3KB
Regulatory Filings
2021-11-07 English
Immutep granted Chinese Patent for eftilagimod alpha 2 pages 229.2KB
Regulatory Filings
2021-11-01 English
Immutep receives EMA scientific advice for Phase 3 in MBC 2 pages 249.1KB
Regulatory Filings
2021-10-28 English
Immutep Quarterly Activities Report & Appendix 4C 9 pages 550.7KB
Interim / Quarterly Report
2021-10-27 English
Annual Report filed on Form 20-F with SEC 177 pages 668.6KB
Annual Report
2021-10-25 English
Annual Report to shareholders 86 pages 1.1MB
Annual Report
2021-10-25 English
Appendix 4G 14 pages 266.6KB
Governance Information
2021-10-25 English
Notice of Annual General Meeting/Proxy Form 25 pages 873.5KB
AGM Information
2021-10-25 English
2021 AGM & Key Dates 2 pages 264.6KB
AGM Information
2021-10-11 English
Immutep to present Phase II TACTI-002 data at SITC 2021 3 pages 291.3KB
Regulatory Filings
2021-10-03 English
Change of Director's Interest Notice - Mr Meyers 3 pages 224.3KB
Director's Dealing
2021-10-03 English
Change of Director's Interest Notice - Mr Chamberlain 3 pages 218.6KB
Director's Dealing
2021-10-03 English
Application for quotation of securities - IMM 6 pages 28.8KB
Share Issue/Capital Change
2021-09-30 English
Notification regarding unquoted securities - IMM 6 pages 28.0KB
Share Issue/Capital Change
2021-09-30 English
Immutep Receives A$3.4 million R&D French Tax Incentive 2 pages 228.4KB
Capital/Financing Update
2021-09-28 English
Immutep to Present at Healthcare Investor Conferences 1
Regulatory Filings
2021-09-27 English
Immutep Corporate Presentation 46 pages 2.2MB
Investor Presentation
2021-09-26 English
Immutep to present final AIPAC Overall Survival data at SITC 2 pages 252.1KB
Regulatory Filings
2021-09-20 English
Recruitment of patients completed for Part B of TACTI-002 3 pages 263.3KB
Capital/Financing Update
2021-08-31 English
Immutep's partner, EOC Pharma, expands efti trial pipeline 2 pages 226.2KB
Capital/Financing Update
2021-08-30 English
Appendix 4E & 2021 Full Year Statutory Accounts 86 pages 1.5MB
Annual Report
2021-08-29 English
Chinese patent granted for anti-LAG-3 antibody LAG525 2 pages 228.7KB
Regulatory Filings
2021-08-26 English
INSIGHT-003 investigator-initiated trial - 1st patient dosed 2 pages 244.5KB
Capital/Financing Update
2021-08-04 English
Change in substantial holding 6 pages 916.2KB
Major Shareholding Notification
2021-08-02 English
Becoming a substantial holder 3 pages 185.7KB
Major Shareholding Notification
2021-08-02 English
Completion of Placement - Tranche 2 2 pages 282.8KB
Capital/Financing Update
2021-07-29 English
Cleansing Notice 1 page 233.1KB
Capital/Financing Update
2021-07-29 English
Application for quotation of securities - IMM 5 pages 26.0KB
Share Issue/Capital Change
2021-07-28 English
Proposed issue of securities - IMM 5 pages 28.2KB
Capital/Financing Update
2021-07-26 English
Change in substantial holding 6 pages 910.4KB
Major Shareholding Notification
2021-07-26 English
2021 EGM Presentation 24 pages 1.5MB
AGM Information
2021-07-25 English
Chairman's EGM Address 2 pages 208.1KB
AGM Information
2021-07-25 English
Results of EGM 2 pages 231.6KB
Declaration of Voting Results & Voting Rights Announcements
2021-07-25 English
Change in substantial holding 6 pages 2.0MB
Major Shareholding Notification
2021-07-22 English
Application for quotation of securities - IMM 6 pages 27.5KB
Capital/Financing Update
2021-07-22 English
Completion of Share Purchase Plan 2 pages 275.6KB
Capital/Financing Update
2021-07-20 English
EGM - Now to be Held as an Online Virtual Meeting 2 pages 237.5KB
Regulatory Filings
2021-07-14 English
Immutep Quarterly Activities Report & Appendix 4C 9 pages 513.0KB
Interim / Quarterly Report
2021-07-12 English
US FDA & IRB approves start of ph2b head & neck cancer trial 2 pages 236.4KB
Capital/Financing Update
2021-07-05 English
Proposed issue of securities - IMM 7 pages 31.3KB
Capital/Financing Update
2021-07-04 English
Change in substantial holding 6 pages 920.7KB
Major Shareholding Notification
2021-06-29 English
Cleansing Notice 1 page 233.0KB
Capital/Financing Update
2021-06-27 English
Application for quotation of securities - IMM 5 pages 26.2KB
Capital/Financing Update
2021-06-24 English
Share Purchase Plan Offer Documents 15 pages 1.1MB
Capital/Financing Update
2021-06-24 English
Notice of Extraordinary General Meeting/Proxy Form 12 pages 540.5KB
Proxy Solicitation & Information Statement
2021-06-24 English
Immutep secures commitments for A$60 million in a Placement 4 pages 359.9KB
Capital/Financing Update
2021-06-20 English
Immutep Capital Raising Presentation 61 pages 2.9MB
Capital/Financing Update
2021-06-20 English
Proposed issue of securities - IMM 5 pages 28.2KB
Capital/Financing Update
2021-06-20 English
Efti to be evaluated in new triple combination therapy trial 2 pages 230.2KB
Regulatory Filings
2021-06-20 English
Trading Halt 2 pages 265.9KB
Capital/Financing Update
2021-06-16 English
Change in substantial holding 6 pages 2.4MB
Major Shareholding Notification
2021-06-14 English
Immutep global webcast slides 38 pages 2.5MB
Investor Presentation
2021-06-08 English
Immutep Reveals a New anti-LAG-3 Research Program 2 pages 245.4KB
Regulatory Filings
2021-06-07 English
Appendix 2A 6 pages 69.5KB
Share Issue/Capital Change
2021-06-07 English
Application for quotation of securities - IMM 6 pages 27.8KB
Capital/Financing Update
2021-06-06 English
Immutep Reports Positive Final Data from INSIGHT-004 trial 3 pages 249.5KB
Regulatory Filings
2021-06-03 English
Immutep Reports Positive Data from its TACTI-002 ph 2 trial 5 pages 306.7KB
Capital/Financing Update
2021-06-03 English
Immutep presentation for Jefferies Healthcare Conference 33 pages 2.4MB
Investor Presentation
2021-06-03 English
Immutep granted European patent for its LAG-3 candidate Efti 2 pages 230.3KB
Regulatory Filings
2021-06-01 English
Immutep enters New Collaboration with Merck KGaA for Efti 2 pages 234.0KB
Capital/Financing Update
2021-05-31 English
Immutep granted Chinese patent for its LAG-3 candidate Efti 2 pages 228.6KB
Regulatory Filings
2021-05-25 English
Immutep to present at Jefferies Healthcare Conference 1
Investor Presentation
2021-05-24 English
Change in substantial holding 6 pages 1.9MB
Major Shareholding Notification
2021-05-19 English
TACTI-002 and INSIGHT-004 abstracts for ASCO 2021 2 pages 309.8KB
Regulatory Filings
2021-05-19 English
Change in substantial holding 6 pages 2.0MB
Major Shareholding Notification
2021-05-17 English
Appendix 2A 16 pages 261.7KB
Capital/Financing Update
2021-05-13 English
Immutep Corporate Presentation 48 pages 3.4MB
Investor Presentation
2021-05-12 English
Operational Update 3 pages 250.4KB
Capital/Financing Update
2021-05-06 English
TACTI-002 & INSIGHT-004 data to be presented at ASCO 2 pages 314.9KB
Regulatory Filings
2021-04-28 English
Immutep Quarterly Activities Report & Appendix 4C 9 pages 596.8KB
Interim / Quarterly Report
2021-04-18 English
Immutep receives A$1,155,055 R&D Tax Incentive 1 pa
Capital/Financing Update
2021-04-15 English
Immutep Investor Update 20 pages 1.9MB
Investor Presentation
2021-04-13 English
Immutep achieves Fast Track designation for Efti from US FDA 2 pages 250.9KB
Regulatory Filings
2021-04-07 English
Immutep announces European Patent Grant for LAG525 2 pages 230.4KB
Regulatory Filings
2021-04-06 English
Change in substantial holding 6 pages 2.0MB
Major Shareholding Notification
2021-03-31 English
Appendix 2A 16 pages 237.7KB
Capital/Financing Update
2021-03-17 English
Immutep collaborates with MSD for phase 2b head & neck trial 2 pages 282.8KB
Capital/Financing Update
2021-03-15 English
Immutep secures second US patent grant for eftilagimod alpha 2 pages 240.0KB
Regulatory Filings
2021-03-08 English
Immutep expands Part B of TACTI-002 collaboration trial 2 pages 300.6KB
Capital/Financing Update
2021-03-04 English
Half Yearly Report and Accounts 30 pages 590.7KB
Interim / Quarterly Report
2021-02-22 English
Immutep Corporate Presentation 45 pages 2.3MB
Investor Presentation
2021-02-01 English
Phase II study for eftilagimod alpha in COVID-19 advances 2 pages 253.3KB
Regulatory Filings
2021-01-26 English
Ulcerative Colitis Phase II Study of GSK2831781 Discontinued 2 pages 276.5KB
Regulatory Filings
2021-01-21 English
Immutep Quarterly Activities Report & Appendix 4C 10 pages 518.4KB
Interim / Quarterly Report
2021-01-21 English
Recruitment of head & neck cancer patients completed for ph2 2 pages 226.6KB
Regulatory Filings
2021-01-06 English
Change in substantial holding 10 pages 200.1KB
Major Shareholding Notification
2021-01-03 English
Resignation and Appointment of Joint Company Secretary 1
Board/Management Information
2021-01-03 English